Rbo & CO LLC Abb Vie Inc. Transaction History

Rbo & CO LLC

$546 Million
Q3 2024

A detailed history of Rbo & CO LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Rbo & CO LLC holds 195,087 shares of ABBV stock, worth $32.2 Million. This represents 7.06% of its overall portfolio holdings.

Number of Shares

195,087

Previous 196,131 0.53%

Holding current value

$32.2 Million

Previous $33.6 Million 14.52%

% of portfolio

7.06%

Previous 6.91%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$163.84 - $199.33 $171,048 - $208,100	-1,044 Reduced 0.53%	195,087 $38.5 Million
Q2 2024 Aug 12, 2024	SELL	$154.79 - $180.76 $113,151 - $132,135	-731 Reduced 0.37%	196,131 $33.6 Million
Q1 2024 May 14, 2024	SELL	$159.82 - $182.1 $14,543 - $16,571	-91 Reduced 0.05%	196,862 $35.8 Million
Q4 2023 Feb 13, 2024	SELL	$137.6 - $154.97 $388,582 - $437,635	-2,824 Reduced 1.41%	196,953 $30.5 Million
Q3 2023 Nov 13, 2023	SELL	$133.59 - $154.65 $160,575 - $185,889	-1,202 Reduced 0.6%	199,777 $29.8 Million
Q2 2023 Aug 11, 2023	SELL	$132.51 - $164.9 $105,477 - $131,260	-796 Reduced 0.39%	200,979 $27.1 Million
Q1 2023 May 12, 2023	SELL	$144.61 - $166.54 $439,325 - $505,948	-3,038 Reduced 1.48%	201,775 $32.2 Million
Q4 2022 Feb 13, 2023	SELL	$138.31 - $165.87 $88,241 - $105,825	-638 Reduced 0.31%	204,813 $33.1 Million
Q3 2022 Nov 14, 2022	SELL	$134.21 - $153.93 $380,485 - $436,391	-2,835 Reduced 1.36%	205,451 $27.6 Million
Q2 2022 Aug 10, 2022	BUY	$137.62 - $174.96 $704,889 - $896,145	5,122 Added 2.52%	208,286 $31.9 Million
Q1 2022 May 16, 2022	SELL	$131.98 - $163.75 $42,893 - $53,218	-325 Reduced 0.16%	203,164 $32.9 Million
Q4 2021 Feb 14, 2022	BUY	$107.43 - $135.93 $7,090 - $8,971	66 Added 0.03%	203,489 $27.6 Million
Q2 2021 Aug 06, 2021	SELL	$105.21 - $117.21 $398,956 - $444,460	-3,792 Reduced 1.83%	203,423 $22.9 Million
Q1 2021 May 17, 2021	BUY	$102.3 - $112.62 $155,905 - $171,632	1,524 Added 0.74%	207,215 $22.4 Million
Q4 2020 Feb 16, 2021	SELL	$80.49 - $108.67 $183,678 - $247,984	-2,282 Reduced 1.1%	205,691 $22 Million
Q3 2020 Nov 13, 2020	BUY	$85.91 - $100.83 $365,375 - $428,829	4,253 Added 2.09%	207,973 $18.2 Million
Q2 2020 Aug 12, 2020	SELL	$73.37 - $98.18 $144,832 - $193,807	-1,974 Reduced 0.96%	203,720 $20 Million
Q1 2020 May 13, 2020	SELL	$64.5 - $97.79 $101,329 - $153,628	-1,571 Reduced 0.76%	205,694 $15.7 Million
Q4 2019 Feb 13, 2020	SELL	$72.13 - $90.25 $114,830 - $143,678	-1,592 Reduced 0.76%	207,265 $18.4 Million
Q3 2019 Nov 12, 2019	BUY	$62.98 - $75.72 $606,938 - $729,713	9,637 Added 4.84%	208,857 $15.8 Million
Q2 2019 Aug 12, 2019	BUY	$65.7 - $83.98 $3.83 Million - $4.89 Million	58,221 Added 41.29%	199,220 $14.5 Million
Q1 2019 May 13, 2019	BUY	$77.14 - $90.79 $129,595 - $152,527	1,680 Added 1.21%	140,999 $11.4 Million
Q4 2018 Feb 13, 2019	BUY	$77.85 - $96.01 $224,441 - $276,796	2,883 Added 2.11%	139,319 $12.8 Million
Q3 2018 Nov 14, 2018	BUY	$88.91 - $98.84 $2.33 Million - $2.59 Million	26,227 Added 23.8%	136,436 $12.9 Million
Q2 2018 Aug 13, 2018	SELL	$89.78 - $106.23 $196,348 - $232,325	-2,187 Reduced 1.95%	110,209 $10.2 Million
Q1 2018 May 11, 2018	SELL	$92.01 - $123.21 $85,569 - $114,585	-930 Reduced 0.82%	112,396 $10.6 Million
Q4 2017 Feb 12, 2018	BUY	$89.56 - $98.21 $372,390 - $408,357	4,158 Added 3.81%	113,326 $11 Million
Q3 2017 Nov 13, 2017	BUY	$69.85 - $89.22 $7.63 Million - $9.74 Million	109,168	109,168 $9.7 Million

Others Institutions Holding ABBV

# of Institutions

3,841

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $292B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rbo & CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rbo & CO LLC with notifications on news.

Account